Explore the Global Magnetic Resonance Imaging (MRI) Contrast Agents Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036

Future Market Insights

Magnetic Resonance Imaging (MRI) Contrast Agents Market

Key Insight

Demand for magnetic resonance imaging contrast agents will increase through 2036, with hospitals at 57.0% of the end user segment in 2026, driven by high contrast use in complex inpatient imaging. The market was valued at USD 1.0 billion in 2025 and is expected to reach USD 1.6 billion by 2036.

April 22, 2026

Anurag Sharma

240 Pages

Cite this Report

Magnetic Resonance Imaging (MRI) Contrast Agents Market

https://www.futuremarketinsights.com/reports/magnetic-resonance-imaging-mri-contrast-agents-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Bayer AG
Bracco Imaging S.p.A
Farmak Group
Fresenius Kabi AG
General Electric
GE HealthCare Technologies Inc
Guerbet
Lantheus Holdings
Viwit Pharmaceuticals
Zydus Lifesciences Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Magnetic Resonance Imaging (MRI) Contrast Agents Market

Key Players

Similar Industry Reports